Clinical trials recruiting in Masaka, Uganda

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions recruiting in Masaka, Uganda

Recruiting trials in Masaka, Uganda

• A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
  NCT06439082 · Phase: Phase 3 · Ages: 12 Years to 100 Years · Sex: All (male and female)
• Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda
  NCT07002866 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 24 Years · Sex: Female

Common questions

How many clinical trials are recruiting in Masaka, Uganda?

2 recruiting trials have at least one study site in Masaka, Uganda.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.